metricas
covid
Buscar en
Revista Española de Cirugía Ortopédica y Traumatología (English Edition)
Toda la web
Inicio Revista Española de Cirugía Ortopédica y Traumatología (English Edition) Soft Tissue Sarcoma: Can a Rescue Procedure be Performed when the First Surgery ...
Journal Information
Vol. 52. Issue 1.
Pages 21-26 (January - February 2008)
Share
Share
Download PDF
More article options
Vol. 52. Issue 1.
Pages 21-26 (January - February 2008)
Original paper
Full text access
Soft Tissue Sarcoma: Can a Rescue Procedure be Performed when the First Surgery was Unsuccessful?
Sarcoma de partes blandas: ¿existe posibilidad de rescate cuando la primera cirugía no fue resolutiva?
Visits
1968
J. Duart-Clementea, M. San-Juliána,
Corresponding author
msjulian@unav.es

Corresponding author: Avda. Pío XII 36. 31008 Pamplona.
, R. Martínez-Mongeb, S. Martín-Algarrab
a Department of Orthopedic and Trauma Surgery. Navarre University Clinic. University of Navarre. Pamplona
b Department of Oncology. University Clinic. University of Navarre
This item has received
Article information
Purpose

The purpose of this paper is to review the experience of our hospital in treating patients diagnosed with a soft-tissue sarcoma (STS) in one of their limbs who sought consultation further to inappropriate surgical resections or a local relapse.

Materials and methods

This is a retrospective study of 64 patients treated for STS in another hospital; the patients were divided into 2 groups: group A, comprised 27 patients where the initial excision proved to be inappropriate («whoops procedure»); group B was made up of 37 patients that had a local recurrence of a STS. The disease-free and accumulated (Kaplan-Meier) survivorship rates were calculated.

Results

Group A: all 27 patients were reoperated and in 12 cases a residual tumoral disease was detected (44%). Twenty-three patients received associated radiotherapy (intraoperatively, brachytherapy and/or external beam radiotherapy). Mean follow up was 67 months (24-216) Three had a local recurrence, two of them requiring amputation. Eleven percent of patients had died at the time of examination. The disease-free survivorship rate at 216 months was 85%.

Group B: 35 of the 37 patients were reoperated (94%). Chemotherapy was used in 21 cases and in four cases isolated limb perfusion was used with TNF and melphalan (10.8%). Twenty-seven patients received radiotherapy (external beam, intraoperative and/or brachytherapy) (72%), 19 of them had received radiotherapy after the first one (70%). In 20 cases (10%) both chemotherapy and radiotherapy were used. Mean follow-up was 80 months (range: 12-264). Sixteen patients had metastasis further to treatment and nineteen had major complications. Forty-three percent of patients had died at the time of this review. Disease-free survivorship at 264 months was 16%.

Conclusions

After a «whoops procedure» it is possible to obtain a high disease-free survivorship rate in patients referred immediately to specialized units. Nevertheless, when local recurrence occurs, the disease-free survivorship rate decreases sharply.

Key words:
soft tissue sarcoma
«whoops procedure»
local recurrence
Objetivo

El objetivo de este trabajo es revisar la experiencia de nuestro centro en el tratamiento de pacientes diagnosticados de sarcoma de partes blandas (SPB) en una extremidad que consultan tras resecciones quirúrgicas inadecuadas o recidiva local.

Material y método

Se trata de un estudio retrospectivo de 64 pacientes remitidos tras el tratamiento de un SPB en otro centro, divididos en 2 grupos: el grupo A, compuesto por 27 pacientes a quienes se realizó una escisión inadecuada inicial (whoops procedure) y el grupo B, con 37 pacientes afectos de una recidiva local de un SPB. Se calculó la tasa de supervivencia libre de enfermedad y la tasa de supervivencia acumulada (Kaplan-Meier).

Resultados

Grupo A: la totalidad de los 27 pacientes fueron reintervenidos y en 12 casos se detectó enfermedad tumoral residual (un 44%). Veintitrés pacientes recibieron radioterapia asociada (intraoperatoria, braquiterapia y/o externa). El seguimiento medio ha sido de 67 meses (24-216) Tres pacientes presentaron recidiva local, uno de los cuales precisó amputación. El 11% de los pacientes habían fallecido en el momento de la revisión. La tasa de supervivencia libre de enfermedad a los 216 meses ha sido del 85%.

Grupo B: 35 de los 37 pacientes fueron reintervenidos (94%). En 21 casos se asoció quimioterapia y en 4 perfusión aislada de la extremidad con factor de necrosis tumoral (TNF) y melfalan (10,8%). Veintisiete pacientes recibieron radioterapia (externa, intraoperatoria y/o braquiterapia) (72%), 19 de ellos habían recibido ya radioterapia después de la primera (70%). En 20 casos (10%) se asoció quimioterapia y radioterapia. La media de seguimiento ha sido de 80 meses (12-264). Dieciséis pacientes presentaron metástasis después del tratamiento y diecinueve tuvieron complicaciones mayores. El 43% de los pacientes había fallecido en el momento de la revisión. La tasa de supervivencia libre de enfermedad a los 264 meses ha sido del 16%.

Conclusiones

Después de una escisión inadecuada inicial se puede obtener una alta tasa de supervivencia libre de enfermedad en pacientes remitidos inmediatamente a centros especializados. Sin embargo, cuando aparece la recidiva local, las posibilidades de supervivencia libre de enfermedad disminuyen drásticamente.

Palabras clave:
sarcoma partes blandas
whoops procedure
recidiva local
Full text is only aviable in PDF
References
[1.]
J.F. Gibbs, R.J. Lee, D.L. Driscoll, B.E. McGrath, E.R. Mindell, W.G. Kraybill.
Clinical importance of late recurrence in softtissue sarcomas.
J Surg Oncol, 73 (2000), pp. 81-86
[2.]
R.C. Ramanathan, R. A’Hern, C. Fisher, J.M. Thomas.
Prognostic index for extremity soft tissue sarcomas with isolated local recurrence.
Ann Surg Oncol, 8 (2001), pp. 278-289
[3.]
A. Jemal, R.C. Tiwari, T. Murray, A. Ghafoor, A. Samuels, E. Ward, et al.
Cancer statistics, 2004.
CA Cancer J Clin, 54 (2004), pp. 8-29
[4.]
K. Mannan, T.W. Briggs.
Soft tissue tumours of the extremities.
[5.]
P. Guftanfson, K.E. Dreinhofer, A. Rydholm.
Soft tissue sarcoma should be treated at a tumor centre.
Acta Orthop Scand, 65 (1994), pp. 47-50
[6.]
H.C. Bauer, C.S. Trovik, T.A. Alvegard, O. Berlin, M. Erlanson, P. Gustafson, et al.
Monitoring referral and treatment in soft tissue sarcoma: study based on 1,851 patients from the Scandinavian Sarcoma Group Register.
Acta Orthop Scand, 72 (2001), pp. 150-159
[7.]
Referral Guidelines for Suspected Cancer. Disponible en: www.doh.gov.uk/cancer/referral.htm.
[8.]
P.F. Choong, I.A. Petersen, A.G. Nascimento, F.H. Sim.
Is radiotherapy important for low-grade soft tissue sarcoma of the extremity?.
Clin Orthop Relat Res, (2001), pp. 191-199
[9.]
A.B.J. Banghu, R. Grimer.
Should soft tissue sarcomas be treated at specialist centre?.
[10.]
J.C. Yang, A.E. Chang, A.R. Baker, W.F. Sindelar, D.N. Danforth, S.L. Topalian, et al.
Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.
J Clin Oncol, 16 (1998), pp. 197-203
[11.]
P.W. Pisters, L.B. Harrison, D.H. Leung, J.M. Woodruff, E.S. Casper, M.F. Brennan.
Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma.
J Clin Oncol, 14 (1996), pp. 859-868
[12.]
C.J. Johnson, P.B. Pynsent, R.J. Grimer.
Clinical features of soft tissue sarcomas.
Ann R Coll Surg Engl, 83 (2001), pp. 203-205
[13.]
M.A. Clark, J.M. Thomas.
Amputation for soft-tissue sarcoma.
Lancet Oncol, 4 (2003), pp. 335-342
[14.]
A. Stojadinovic, D.P. Jaques, D.H. Leung, J.H. Healey, M.F. Brennan.
Amputation for recurrent soft tissue sarcoma of the extremity: indications and outcome.
Ann Surg Oncol, 8 (2001), pp. 509-518
[15.]
J.M. Coindre, P. Terrier, N.B. Bui, F. Bonichon, F. Collin, V. Le Doussal, et al.
Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group.
J Clin Oncol, 14 (1996), pp. 869-877
[16.]
F.C. Eilber, G. Rosen, S.D. Nelson, M. Selch, F. Dorey, J. Eckardt, et al.
High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality.
[17.]
G.K. Zagars, M.T. Ballo, P.W. Pisters, R.E. Pollock, S.R. Patel, R.S. Benjamin, et al.
Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 225 patients.
Cancer, 97 (2003), pp. 2530-2543
[18.]
C.P. Gibbs, T.D. Peabody, A.J. Mundt, A.G. Montag, M.A. Simon.
Oncological outcomes of operative treatment of subcutaneous soft-tissue sarcomas of the extremities.
J Bone Joint Surg Am, 79 (1997), pp. 888-897
[19.]
C.S. Trovik, H.C. Bauer, T.A. Alvegard, H. Anderson, C. Blomqvist, O. Berlin, et al.
Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register.
Eur J Cancer, 36 (2000), pp. 710-716
[20.]
S. Noria, A. Davis, R. Kandel, J. Levesque, B. O'Sullivan, J. Wunder, et al.
Residual disease following unplanned excision of soft-tissue sarcoma of an extremity.
J Bone Joint Surg Am, 78 (1996), pp. 650-655
[21.]
C. Zornig, M. Peiper, S. Schroder.
Re-excision of soft tissue sarcoma after inadequate initial operation.
Br J Surg, 82 (1995), pp. 278-279
[22.]
K.A. Siebenrock, R. Hertel, R. Ganz.
Unexpected resection of soft-tissue sarcoma. More mutilating surgery, higher local recurrence rates, and obscure prognosis as consequences of improper surgery.
Arch Orthop Trauma Surg, 120 (2000), pp. 65-69
[23.]
H. Sugiura, M. Takahashi, H. Katagiri, Y. Nishida, H. Nakashima, M. Yonekawa, et al.
Additional wide resection of malignant soft tissue tumors.
Clin Orthop Relat Res, (2002), pp. 201-210
[24.]
J.R.F.C. Goodlad, M.A. Smith.
Surgical resection of primary soft-tissue sarcoma. Incidence of residual tumour in 95 patients needing re-excision after local resection.
J Bone Joint Surg Br, B (1996), pp. 658-661
[25.]
A.N.E.A. Van Geel, P. Hanssens, P. Schmitz.
Factors influencing prognosis after initial inadequate excision (IIE) for soft tissue sarcoma.
[26.]
T.E. Lans, D.J. Grunhagen, J.H. de Wilt, A.N. van Geel, A.M. Eggermont.
Isolated limb perfusions with tumor necrosis factor and melphalan for locally recurrent soft tissue sarcoma in previously irradiated limbs.
Ann Surg Oncol, 12 (2005), pp. 406-411
[27.]
R. Martínez-Monge, M. San Julián, S. Amillo, M. Cambeiro, L. Arbea, J. Valero, et al.
Perioperative high-dose-rate brachytherapy in soft tissue sarcomas of the extremity and superficial trunk in adults: initial results of a pilot study.
Brachytherapy, (2005), pp. 64-70
[28.]
R. Martínez-Monge, M. Cambeiro, M. San-Julián, L. Sierrasesumaga.
Use of brachytherapy in children with cancer: the search for an uncomplicated cure.
Lancet Oncol, 7 (2006), pp. 157-166
Copyright © 2008. Sociedad Española de Cirugía Ortopédica y Traumatología (SECOT). All rights reserved
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos